Giles DudleyCBO at Stimuliver ApSPresenter
Profile
CBO at Stimuliver, a regenerative medicine company spun out of the University of Edinburgh. He brings 15+ years’ experience in biotech commercialisation, with a focus on fundraising, licensing, and cross-border partnerships. He has helped raise over €100M for early-stage ventures and previously led global BD efforts at the BioInnovation Institute in Denmark.
Agenda Sessions
Cell and Gene Therapies: Stimuliver ApS
, 15:10View Session